7-geranylgeranyloxycoumarin | 1338059-06-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 7-geranylgeranyloxycoumarin
• 英文别名: 7-((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyloxy)-oxy-2H-chromen-2-one；7-Geranylgeranyloxy-coumarin；7-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoxy]chromen-2-one
• CAS: 1338059-06-5
• 化学式: C₂₉H₃₈O₃
• 分子量: 434.619
• InChiKey: JKIYQCXQVMQTDT-ONFFHHOFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9
• 重原子数：
  32
• 可旋转键数：
  12
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  香叶基香叶醇 在 sodium hydride 、 三乙胺 、 lithium bromide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 1.25h， 生成 7-geranylgeranyloxycoumarin
  参考文献：
  名称：

  Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative

  摘要：

  A series of hydroxycoumarin derivatives has been synthesized and evaluated against human pancreatic PANC-1 cancer cells under nutrient-deprived conditions. Several compounds exhibited 100% preferential cytotoxicity at low micromolar concentrations under nutrition starvation, and showed no cytotoxicity under nutrient-rich conditions. In this study, a novel geranylgeranylated ether coumarin derivative 9 was found to exhibit the highest cytotoxic activity of 6.25 mu M within 24 h. The preferential anti-tumor activity exhibited by compound 9 against PANC-1 under low oxygen and nutrient environment illustrates its great potential as a promising lead structure for the development of novel agents to combat pancreatic cancer. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.08.005

文献信息

• Investigation of the cytotoxicity of bioinspired coumarin analogues towards human breast cancer cells
  作者：Leonidas Gkionis、Eleni Kavetsou、Alexandros Kalospyros、Dimitris Manousakis、Miguel Garzon Sanz、Sam Butterworth、Anastasia Detsi、Annalisa Tirella

  DOI：10.1007/s11030-020-10082-6

  日期：2021.2

  Coumarins possess a wide array of therapeutic capabilities, but often with unclear mechanism of action. We tested a small library of 18 coumarin derivatives against human invasive breast ductal carcinoma cells with the capacity of each compound to inhibit cell proliferation scored, and the most potent coumarin analogues selected for further studies. Interestingly, the presence of two prenyloxy groups (5,7-diprenyloxy-4-methyl-coumarin,4g) or the presence of octyloxy substituent (coumarin4d) was found to increase the potency of compounds in breast cancer cells, but not against healthy human fibroblasts. The activity of potent compounds on breast cancer cells cultured more similarly to the conditions of the tumour microenvironment was also investigated, and increased toxicity was observed. Results suggest that tested coumarin derivatives could potentially reduce the growth of tumour mass. Moreover, their use as (combination) therapy in cancer treatment might have the potential of causing limited side effects.

  摘要：香豆素具有广泛的治疗能力，但其作用机制通常不清楚。我们对18种香豆素衍生物进行了测试，针对具有抑制细胞增殖能力的每种化合物进行评分，选择了最有效的香豆素类似物进行进一步研究。有趣的是，在乳腺癌细胞中发现了两个异戊氧基基团（5,7-二异戊氧基-4-甲基香豆素，4g）或辛氧基取代基（香豆素4d）的存在可以增加化合物在乳腺癌细胞中的活性，但对健康的人类成纤维细胞没有影响。还研究了强有效化合物在培养条件更类似于肿瘤微环境的乳腺癌细胞上的活性，并观察到了增加的毒性。结果表明，测试的香豆素衍生物可能有潜力减少肿瘤质量的增长。此外，在癌症治疗中将它们用作（联合）疗法可能会导致有限的副作用。
• Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative
  作者：Tehsina Devji、Claire Reddy、Christina Woo、Suresh Awale、Shigetoshi Kadota、Dora Carrico-Moniz

  DOI：10.1016/j.bmcl.2011.08.005

  日期：2011.10

  A series of hydroxycoumarin derivatives has been synthesized and evaluated against human pancreatic PANC-1 cancer cells under nutrient-deprived conditions. Several compounds exhibited 100% preferential cytotoxicity at low micromolar concentrations under nutrition starvation, and showed no cytotoxicity under nutrient-rich conditions. In this study, a novel geranylgeranylated ether coumarin derivative 9 was found to exhibit the highest cytotoxic activity of 6.25 mu M within 24 h. The preferential anti-tumor activity exhibited by compound 9 against PANC-1 under low oxygen and nutrient environment illustrates its great potential as a promising lead structure for the development of novel agents to combat pancreatic cancer. (C) 2011 Elsevier Ltd. All rights reserved.